Search

everythinglearnresearchcommunity

for

Search:↓

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

Some cannabinoid derivatives may be more effective than current drugs at targeting proteins relevant to prostate cancer treatment.

Antisense oligonucleotides can reduce androgen receptor levels in skin cells, suggesting potential for treating skin disorders.

Selective androgen receptor modulators (SARMs) are a promising type of drug for various health conditions due to their targeted actions.

Antiandrogens can treat excess body hair and hair loss by blocking male hormones.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

Artocarpus heterophyllus seed extract may help treat prostate inflammation without side effects.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

Allergic reactions to blood thinners are rare but can be serious, requiring careful management and alternative treatments.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Long-term use of androgens can help manage Hereditary Angioedema (HAE) but may cause serious side effects, so alternative treatments with fewer side effects are being considered.

Potassium channel openers show promise for treating heart disease and other conditions, but more research is needed to fully understand their effects and safety.

Promising cancer treatments were found, but the manufacturer closed.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

New treatments improved blood pressure control in patients with resistant hypertension.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Dutasteride works better than finasteride for hair loss, with both being safe to use.

5 alpha reductase inhibitors can cause sexual, cognitive, and muscle side effects, and may slightly increase aggressive cancer risk.

Leonuri Herba alkaloids may help treat hormone-induced enlarged prostate in rats.

Targeting amphiregulin may improve treatment for fibrosis and cancer.

Side effects of drugs can lead to the discovery of new treatments.

The new assay can help develop products for hair re-growth.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

A new topical treatment for hair loss shows promise by targeting androgen receptors.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Olanzapine reduces stress-related anxiety in rats when given acutely.

Finasteride weakens the bone-protective effects of certain blockers in low androgen conditions.